Target intelligence / Profile preview

ribosomal protein L3 pseudogene 10 (RPL3P10)

Target: RPL3P10
Molecular classification: Other, Pseudogene

Overview

Ribosomal protein L3 pseudogene 10 (RPL3P10) is a processed pseudogene in humans. It is related to the ribosomal protein L3 gene (RPL3), which encodes a structural component of the 60S ribosomal subunit. However, as a pseudogene, RPL3P10 does not encode a functional protein and has no established biological function, disease role, or known drug interactions. There is no evidence supporting its consideration as a therapeutic target. Most processed pseudogenes like RPL3P10 are non-functional copies of genes dispersed through the genome and are typically not transcribed or translated[4][6].

Other names: RPL3P10

Beyond the preview

Go deeper on ribosomal protein L3 pseudogene 10 (RPL3P10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L3 pseudogene 10 (RPL3P10).

Explore the full profile